Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s):  FENC

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.


TSX:FRX - Post by User

Post by commissionson Apr 23, 2004 1:08pm
301 Views
Post# 7394193

blue skies not to far ahead

blue skies not to far aheadGentleman, my sources have led me to believe that this guy selling at .50 is the guy who was at .64-.65 and has just come down to liquidate the balance of his position.We should thank him, he was selling his stock at 50% off at.65 and now he has knocked off another 25%. The ACSO show is just around the corner and these guys will be getting alot of coverage. I would imagine that a US listing will also be being awarded in that time frame from discussions that I have had with the company. Once US listed the liquidity should be in the 1-2 million share range daily and an a**hole like this would get cleared out in days not months. If this goes much lower I would be surprised, and if it does I will be re-arranging my porfolio to acquire more. Remember who took down the financing-these guys are very good at what they do and you can bet that they were considerably more in the know than the retail smucks who are pannicking. It won't be long and we will be sucking back some cold ones recanting the story of the 10 bagger ( US ). GO HOME AND DO YOUR RETIREMENT PLANNING IN ADVANCE Commissions
Bullboard Posts